Omega-3 Fatty Acids for Hyperactivity Treatment in Autism Spectrum Disorder

NCT01694667 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Autism Spectrum Disorders
Hyperactivity

Interventions

DRUG: Omega-3 Fatty Acids
OTHER: Placebo

Sponsor

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Collaborators

[object Object]